comparemela.com
Home
Live Updates
BioLineRx : Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024 : comparemela.com
BioLineRx : Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
...
Related Keywords
United States ,
Modiin ,
Israel General ,
Israel ,
New York ,
Russia ,
Georgia ,
Washington ,
Georgia World Congress Center ,
Atlanta ,
Ukraine ,
American ,
Russian ,
John Lacey ,
Twitterand Linkedin ,
Moran Meir ,
Jeffreyr Skaar ,
Philipa Serlin ,
Lifesci Advisors ,
International Society For Pharmacoeconomics ,
Outcomes Research ,
Exchange Commission On ,
Securities Exchange ,
Value In Health ,
Society For Health Economics ,
Biolinerx Ltd ,
American Cancer Society ,
Biolinerx United States Inc ,
Trinity Life Sciences ,
Ma Ayan Street ,
Principal Executive Offices ,
Securities Exchange Act ,
Linerx Announces Poster Presentation ,
Economic Model Data ,
Hematopoietic Stem Cell Mobilization ,
Multiple Myeloma ,
Presentation Today ,
International Society ,
Professional Society ,
Health Economics ,
World Congress Center ,
Institutional Level Impact ,
Additional Apheresis Days ,
Healthcare Resource Utilization ,
Jenniferl Lessor ,
Biolinerx United States ,
Economic Evaluation ,
Hypersensitivity Reactions ,
Site Reactions ,
Cell Mobilization ,
Tumor Cell Mobilization ,
Private Securities Litigation Reform Act ,
Exchange Commission ,
Key Statistics About Multiple ,
Sci Advisors ,
Markets ,
comparemela.com © 2020. All Rights Reserved.